IPXL Impax Laboratories Inc.

$19.75 -3.66%

729,288 Shares Traded
1,053,492 Average Volume (last 30 days)

as of March 23, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Made on the Day: $7.64 million
If Intiated on the First, Shorts Have Realized a Year to Date Return of:-16.48%
If Intiated One Month Ago, Shorts Have Realized a Return of:-4.06%
If Initiated Five Days ago, Shorts Have Realized a Return of:2.61%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bullish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 14.09%
Short Interest10.19 million
Float72.3 million
Short Ratio10.48
Market Cap$1.52 billion
Market Maker ActivityDaily Short Volume


Amneal Gains Approval for Erythromycin Tablets USP (PR Newswire)
Amneal Pharmaceuticals and Impax Laboratories to Present at the Barclays Global Healthcare Conference (PR Newswire)
Premarket analyst action - healthcare (SeekingAlpha)
Endo Pharmaceuticals Will Be Crushed By Opioid Litigation (SeekingAlpha)
Impax Laboratories (IPXL) Q4 2017 Results - Earnings Call Transcript (SeekingAlpha)
Impax Laboratories, Inc. 2017 Q4 - Results - Earnings Call Slides (SeekingAlpha)
Amneal Launches Generic for Tamiflu® Oral Suspension (PR Newswire)
Impax Lab EPS in-line, misses on revenue (SeekingAlpha)
Impax Reports Fourth Quarter and Full Year 2017 Results (PR Newswire)
Notable earnings before Thursday's open (SeekingAlpha)

Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 66.9%

Earnings Stats

PE Ratio 31.27
Dividend Yield 0%
Peer EarningsEarnings Calendar


200 Day Moving Average $18.69
50 Day Moving Average $19.89
52 Week High $25.7
52 Week Low $8.8

Data provided for free by IEX. Questions? Read the FAQ